Fintel on MSN9h
Evercore ISI Group Upgrades CRISPR Therapeutics (CRSP)
Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
Evercore ISI Remains a Hold on Tyler Technologies (TYL)
Evercore ISI analyst Kirk Materne maintained a Hold rating on Tyler Technologies (TYL – Research Report) yesterday and set a price target of ...
Evercore ISI Reaffirms Their Buy Rating on Nisource (NI)
In a report released yesterday, Durgesh Chopra from Evercore ISI maintained a Buy rating on Nisource (NI – Research Report), with a price ...
CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Evercore ISI Issues Positive Forecast for Confluent (NASDAQ:CFLT) Stock Price
Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...
Evercore ISI Boosts The Carlyle Group (NASDAQ:CG) Price Target to $52.00
The Carlyle Group (NASDAQ:CG – Get Free Report) had its price target hoisted by analysts at Evercore ISI from $51.00 to $52.00 in a report issued on Wednesday,Benzinga reports. The firm presently has ...
Evercore ISI lifts CRISPR stock rating, target to $99
Evercore ISI analysts upgraded CRISPR Therapeutics stock from an In Line to an Outperform rating and increased the price target significantly to $99 from the previous $60. The upgrade comes as ...
Crowdfund Insider5h
Bitcoin Mining Firm Riot Platforms Shares Updates Including Formal Evaluation of AI and HPC Uses
Riot Platforms, Inc, an industry participant focused on vertically integrated Bitcoin mining, announced the appointment of ...